Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-25 @ 2:08 PM
Study NCT ID:
NCT03503266
Status:
COMPLETED
Last Update Posted:
2023-05-15
First Post:
2018-03-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Mass Balance Study With MT-7117
Sponsor:
Tanabe Pharma America, Inc.
Organization:
Study Overview
Official Title:
An Open-label, Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-MT-7117 After a Single Oral Dose to Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MT-7117 MB
Brief Summary:
This is a single-centre, open-label, mass balance study in healthy male subjects utilising a single oral dose of \[14C\] MT 7117.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2017-004549-25 | EUDRACT_NUMBER | None | View |